| Home | E-Submission | Sitemap | Contact us |  
top_img
International Journal of Arrhythmia 2018;19(2): 82-125.
doi: https://doi.org/10.18501/arrhythmia.2018.008
2018 대한부정맥학회 심실빈맥 전극도자 절제술 가이드라인 Part 3
조영진1, 김성환2, 김유리3, 김윤년4, 김주연5, 김태훈6, 남기병7, 노승영8, 박경민9, 박형섭4, 박희남6, 배은정10, 오세일11, 윤남식12, 이만영13, 조용근14, 진은선15, 차태준16, 최종일17, 김 준7
1분당서울대학교병원
2가톨릭대학교 서울성모병원
3가톨릭대학교 인청성모병원
4계명대학교 동산의료원
5가톨릭대학교 의정부성모병원
6연세대학교 세브란스병원
7울산대학교 서울아산병원
8동국대학교병원
9성균관대학교 삼성서울병원
10서울대학교 어린이병원
11서울대학교병원
12전남대학교병원
13가톨릭대학교 여의도성모병원
14경북대학교병원
15경희대학교 강동경희대병원
16고신대학교 복음병원
17고려대학교 안암병원
2018 KHRS Guidelines for Catheter Ablation of Ventricular Arrhythmias – Part3
Youngjin Cho 1, Sung-Hwan Kim 2, Yoo Ri Kim 3, Yoon-Nyun Kim 4, Ju-Youn Kim 5, Tae-Hoon Kim 6, Gi-Byoung Nam 7, Seung-Young Roh 8, Kyoung-Min Park 9, Hyoung-Seob Park 4, Hui-Nam Pak 6, Eun-Jung Bae 10, Seil Oh 11, Namsik Yoon 12, Man Young Lee 13, Yongkeun Cho 14, Eun-Sun Jin 15, Tae-Joon Cha 16, Jong-Il Choi 17, Jun Kim 7
Corresponding Author: Jun Kim ,Email: mdjunkim@gmail.com
Received: April 23, 2018.  Accepted: June 12, 2018.
Abstract
Treatment of ventricular arrhythmias (VA) usually involves managing the underlying cardiac conditions that cause the arrhythmia. However, managing the underlying disease is often challenging, and catheter ablation, or treatment targeting the VA itself might be required in a few patients. In this article, we explored evidence and recommendations regarding the treatment of VA in patients with structural heart disease focusing on the utilization of catheter ablation in these patients. The administration of optimal medical therapy, insertion of an implantable cardioverter-defibrillator, or resynchronization therapy improves survival in patients with left ventricular dysfunction. The role of catheter ablation in preventing sudden cardiac death remains uncertain in this population. In patients with coronary artery disease, reversing myocardial ischemia via revascularization is important in managing VA. Catheter ablation is recommended in patients with recurrent ventricular tachycardia in a setting of ischemic heart disease. In patients with non-ischemic cardiomyopathies such as dilated cardiomyopathy or hypertrophic cardiomyopathy, catheter ablation may be considered for those presenting with drug-refractory ventricular tachycardia.